Creating a new device to assist patients with heart circulation issues.
Development of a Percutaneous Double Lumen Cannula-Based Cavopulmonary Assist System Toward Clinical Application
['FUNDING_R01'] · UNIVERSITY OF KENTUCKY · NIH-11019787
This study is working on a new device to help people with cavopulmonary failure after heart surgery, making it easier for them to get around without needing more major surgery.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF KENTUCKY (nih funded) |
| Locations | 1 site (LEXINGTON, UNITED STATES) |
| Trial ID | NIH-11019787 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a new percutaneous double lumen cannula system designed to assist patients with cavopulmonary failure, a condition that can arise after certain heart surgeries. The device aims to provide total ambulatory support by connecting to the existing heart structure without the need for major surgery. The research involves designing and optimizing the cannula to minimize complications and ensure effective performance. By using advanced modeling techniques, the team will tailor the device to fit individual patient anatomies.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients who have undergone a total cavopulmonary connection and are experiencing cavopulmonary failure.
Not a fit: Patients who do not have a history of single ventricle defects or those who are not experiencing cavopulmonary failure may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the quality of life and survival rates for patients suffering from cavopulmonary failure.
How similar studies have performed: While the approach of developing a percutaneous assist device is innovative, similar technologies have shown promise in other cardiac applications, indicating potential for success.
Where this research is happening
LEXINGTON, UNITED STATES
- UNIVERSITY OF KENTUCKY — LEXINGTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WANG, DONGFANG — UNIVERSITY OF KENTUCKY
- Study coordinator: WANG, DONGFANG
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.